Cover Image
Market Research Report

Anti-Parkinson's Drugs: Global Markets to 2022

Published by BCC Research Product code 611045
Published Content info 172 Pages
Delivery time: 1-2 business days
Price
Back to Top
Anti-Parkinson's Drugs: Global Markets to 2022
Published: March 7, 2018 Content info: 172 Pages
Description

Report Highlights

The global anti-Parkinson's drugs market should reach $5.7 billion by 2022 from $4.2 billion in 2017 at a compound annual growth rate (CAGR) of 6.1% from 2017 to 2022.

Report Includes:

  • 95 data tables
  • An overview of the global market for anti-Parkinson's drugs and their future demand
  • Analyses of global market trends, with data from 2013-2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Analyses of the major factors and technological advances such as biomarkers, 3D printed drugs, mobile applications and wearable technologies in the monitoring and treatment of Parkinson's disease
  • Discussion of the major segments of the anti-Parkinson's drugs, i.e., dopaminergic drugs, dopamine agonists, enzyme inhibitors and other anti-Parkinson's medications
  • Company profiles of the major players in the market, including AbbVie, Mylan Laboratories, Valeant Pharmaceuticals and Novartis

Report Scope

This research report categorizes the anti-Parkinson's drugs market by type. Product types include low dopaminergic, dopamine agonists, enzyme inhibitors and other anti-Parkinson's medications.

Analyst Credentials

Led by Research Head Karthik Arun, the BCC Research Staff is comprised of expert analysts skilled in conducting primary research, secondary research and data analysis and who have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in microbiology, electrical engineering, business administration and surgery, among others.

Table of Contents
Product Code: PHM193A

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Anti-Parkinson's Drugs Market Characteristics

Chapter 4: Anti-Parkinson's Drugs Market Size and Growth

  • Historic Market Growth
    • Drivers of the Market
    • Restraints on the Market
  • Forecast Market Growth
    • Drivers of the Market
    • Restraints on the Market

Chapter 5: Anti-Parkinson's Drugs Market Trends and Strategies

  • New Medication to Help the Body Absorb Parkinson's Disease Medication
  • Free Water Biomarker to Track Changes in Brain
  • 3D Printing Technology

Chapter 6: PESTLE Analysis

  • Political
    • Government Financial Support
    • Uncertain Political Policies
    • Government Intervention
  • Economic
    • Wealth
    • Globalization
    • Emerging Markets
  • Social
    • Aging Global Population
    • Health Consciousness and Awareness
    • Traditional Medicine Continues to Pose Threat to Market
    • Shortage of Skill
  • Technological
    • Technological Breakthroughs
    • Wearable Technology and Hardware Advancements
    • Internet Penetration and Mobile Applications
  • Legal
    • Stringent Regulations and Long Approval Procedures
    • Tax Exemptions Initiatives and Subsidies
    • Investment Regulations
  • Environmental

Chapter 7: Anti-Parkinson's Drugs Market Segmentation

  • Global Anti-Parkinson's Drugs Market, by Segment
  • Global Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
  • Dopaminergics Market
    • Market Characteristics
    • Market Trends and Strategies
  • Dopamine Agonists Market
    • Market Characteristics
    • Market Trends and Strategies
  • Enzyme Inhibitors Market
    • Market Characteristics
    • Market Trends and Strategies
  • Other Anti-Parkinson's Medications Market
    • Market Characteristics

Chapter 8: Anti-Parkinson's Drugs Market Regional and Country Analysis

  • Global Anti-Parkinson's Drugs Market, by Region
  • Global Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Region
  • Global Anti-Parkinson's Drugs Market Segmentation, by Region, 2017
  • Global Anti-Parkinson's Drugs Market, by Country
  • Global Anti-Parkinson's Drugs Market, Historic and Forecast, by Country
  • Global Anti-Parkinson's Drugs Market Segmentation, 2017, by Country

Chapter 9: Global Anti-Parkinson's Drugs Market Comparison with Macro

  • Economic Factors
  • Global Per Capita Average Anti-Parkinson's Drugs Market Expenditure
  • Per Capita Average Anti-Parkinson's Drugs Market Expenditure, by Country

Chapter 10: Asia-Pacific Anti-Parkinson's Drugs Market

  • Asia-Pacific Anti-Parkinson's Drugs Market Overview
    • Region Information
    • Market Information
    • Prevalence of Parkinson's Disease
    • Government Initiatives
    • Major Contracts/ Research and Development Projects
    • Regulatory Bodies
    • Regulations
    • Major Associations
    • Export and Import Duties on Anti-Parkinson Drugs
    • Taxes Levied
    • Corporate Tax Structure
    • Competitive Landscape
  • Asia-Pacific Anti-Parkinson's Drugs Market Historic Market, 2013-2017
  • Asia-Pacific Anti-Parkinson's Drugs Market Forecast Market
  • Asia-Pacific Anti-Parkinson's Drugs Market, by Segment
  • Asia-Pacific Anti-Parkinson's Drugs Market, Historic and Forecast CAGR, by Segment

Chapter 11: Asia-Pacific Anti-Parkinson's Drugs Market: Country Analysis

  • China Anti-Parkinson's Drugs Market Overview
    • Country Information
    • Market information
    • Prevalence of Parkinson's Disease
    • Government Initiatives
    • Major Contracts/ Research and development Projects
    • Regulatory Bodies
    • Regulations
    • Major Associations
    • Export and Import Duties on Anti-Parkinson Drugs
    • Taxes Levied
    • Corporate Tax Structure
    • Competitive Landscape
    • China Anti-Parkinson's Drugs Market Historic Market, 2013-2017
    • China Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
    • China Market Size, by Segment
    • China Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
  • India Anti-Parkinson's Drugs Market Overview
    • Country Information
    • Market Information
    • Prevalence of Parkinson's Disease
    • Government Initiatives
    • Major Contracts/ Research and Development Projects
    • Regulatory Bodies
    • Regulations
    • Major Associations
    • Import and Export Duties
    • Taxes Levied
    • Corporate Tax Structure
    • Competitive Landscape
    • India Anti-Parkinson's Drugs Market Historic Market, 2013-2017
    • India Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
    • India Market Size, by Segment
    • India Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
  • Japan Anti-Parkinson's Drugs Market Overview
    • Country Information
    • Market Information
    • Prevalence of Parkinson's Disease
    • Government Initiatives
    • Major Contracts/ Research and Development Projects
    • Regulatory Bodies
    • Regulations
    • Major Associations
    • Import and Export Duties on Anti-Parkinson Drugs
    • Taxes Levied
    • Corporate Tax Structure
    • Competitive Landscape
    • Japan Anti-Parkinson's Drugs Market Historic Market, 2013-2017
    • Japan Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
    • Japan Market Size, by Segment
    • Japan Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
  • Australia Anti-Parkinson's Drugs Market
    • Australia Anti-Parkinson's Drugs Market Historic Market, 2013-2017
    • Australia Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
    • Australia Market Size, by Segment
    • Australia Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment

Chapter 12: Western Europe Anti-Parkinson's Drugs Market

  • Western European Anti-Parkinson's Drugs Market Overview
    • Region Information
    • Market Information
    • Prevalence of Parkinson's Disease
    • Government Initiatives
    • Major Contracts/ Research and Development Projects
    • Regulatory Bodies
    • Regulations
    • Major Associations
    • Taxes Levied
    • Corporate Tax Structure
    • Competitive Landscape
  • Western Europe Anti-Parkinson's Drugs Historic Market, 2013-2017
  • Western Europe Anti-Parkinson's Drugs Forecast Market, 2017-2022
  • Western Europe Market Size, by Segment
  • Western Europe Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment

Chapter 13: Western Europe Anti-Parkinson's Drugs Market: Country Analysis

  • UK Anti-Parkinson's Drugs Market Overview
    • Country Information
    • Market information
    • Prevalence of Parkinson's Disease
    • Government Initiatives
    • Major Contracts/ Research and Development Projects
    • Regulatory Bodies
    • Regulations
    • Major Associations
    • Export and Import Duties on Anti-Parkinson Drugs
    • Taxes Levied
    • Corporate Tax Structure
    • Competitive Landscape
    • UK Anti-Parkinson's Drugs Historic Market, 2013-2017
    • UK Anti-Parkinson's Drugs Forecast Market, 2017-2022
    • UK Market Size, by Segment
    • UK Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
  • Germany Anti-Parkinson's Drugs Market
    • Germany Anti-Parkinson's Drugs Historic Market, 2013-2017
    • Germany Anti-Parkinson's Drugs Forecast Market, 2017-2022
    • Germany Market Size, by Segment
    • Germany Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
  • France Anti-Parkinson's Drugs Market
    • France Anti-Parkinson's Drugs Market Historic Market, 2013-2017
    • France Anti-Parkinson's Drugs Forecast Market, 2017-2022
    • France Market Size, by Segment
    • France Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
  • Italy Anti-Parkinson's Drugs Market
    • Italy Anti-Parkinson's Drugs Market Historic Market, 2013-2017
    • Italy Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
    • Italy Market Size, by Segment
    • Italy Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022,
  • Spain Anti-Parkinson's Drugs Market
    • Spain Anti-Parkinson's Drugs Market Historic Market, 2013-2017
    • Spain Anti-Parkinson's Drugs Forecast Market, 2017-2022
    • Spain Market Size, by Segment
    • Spain Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022

Chapter 14: Eastern Europe Anti-Parkinson's Drugs Market

  • Eastern European Anti-Parkinson's Drugs Market Overview
    • Region Information
    • Market Information
    • Prevalence of Parkinson's Disease
    • Government Initiatives
    • Major Contracts/ Research and Development Projects
    • Regulatory Bodies
    • Regulations
    • Major Associations
    • Export and Import Duties On Anti-Parkinson Drugs
    • Taxes Levied
    • Corporate Tax Structure
    • Competitive Landscape
  • Eastern Europe Anti-Parkinson's Drugs Historic Market, 2013-2017
  • Eastern Europe Anti-Parkinson's Drugs Forecast Market, 2017-2022
  • Eastern Europe Market Size, by Segment
  • Eastern Europe Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022

Chapter 15: Eastern Europe Anti-Parkinson's Drugs Market: Country Analysis

  • Russia Anti-Parkinson's Drugs Market
    • Russia Anti-Parkinson's Drugs Historic Market, 2013-2017
    • Russia Anti-Parkinson's Drugs Forecast Market, 2017-2022
    • Russia Market Size, by Segment
    • Russia Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022

Chapter 16: North America Anti-Parkinson's Drugs Market

  • North America Anti-Parkinson's Drugs Market Overview
    • Region Information
    • Market Information
    • Prevalence of Parkinson's Disease
    • Government Initiatives
    • Major Contracts/ Research and Development Projects
    • Regulatory Bodies
    • Regulations
    • Major Associations
    • Taxes Levied
    • Corporate Tax Structure
    • Competitive Landscape
  • North America Anti-Parkinson's Drugs Historic Market, 2013-2017
  • North America Anti-Parkinson's Drugs Forecast Market, 2017-2022
  • North America Market Size, by Segment
  • North America Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022

Chapter 17: North America Anti-Parkinson's Drugs Market: Country Analysis

  • USA Anti-Parkinson's Drugs Market
    • USA Anti-Parkinson's Drugs Market Historic Market, 2013-2017
    • USA Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
    • USA Market Size, by Segment
    • USA Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment

Chapter 18: South America Anti-Parkinson's Drugs Market

  • South America Anti-Parkinson's Drugs Market Overview
    • Region Information
    • Market Information
    • Prevalence of Parkinson's Disease
    • Government Initiatives
    • Major Contracts/ Research and Development Projects
    • Regulatory Bodies
    • Regulations
    • Major Associations
    • Taxes Levied
    • Corporate Tax Structure
    • Competitive Landscape
  • South America Anti-Parkinson's Drugs Historic Market, 2013-2017
  • South America Anti-Parkinson's Drugs Forecast Market, 2017-2022
  • South America Market Size, by Segment
  • South America Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022

Chapter 19: South America Anti-Parkinson's Drugs Market: Country Analysis

  • Brazil Anti-Parkinson's Drugs M
    • Brazil Anti-Parkinson's Drugs Historic Market, 2013-2016
    • Brazil Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
    • Brazil Market Size, by Segment
    • Brazil Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022

Chapter 20: Middle East Anti-Parkinson's Drugs Market

  • Middle Anti-Parkinson's Drugs Market Overview
    • Region Information
    • Market information
    • Prevalence of Parkinson's Disease
    • Government Initiatives
    • Major Contracts/ Research and Development Projects
    • Regulations
    • Regulatory Bodies
    • Major Associations
    • Competitive Landscape
  • Middle East Anti-Parkinson's Drugs Historic Market, 2013-2017
  • Middle East Anti-Parkinson's Drugs Forecast Market, 2017-2022
  • Middle East Market Size, by Segment
  • Middle East Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022

Chapter 21: Africa Anti-Parkinson's Drugs Market

  • Africa Anti-Parkinson's Drugs Market Overview
    • Region Information
    • Market information
    • Prevalence of Parkinson's Disease
    • Government Initiatives
    • Regulatory Bodies
    • Major Associations
    • Export and Import Duties on Anti-Parkinson Drugs
    • Competitive Landscape
  • Africa Anti-Parkinson's Drugs Historic Market, 2013-2017
  • Africa Anti-Parkinson's Drugs Forecast Market, 2017-2022
  • Africa Market Size, by Segment
  • Africa Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022

Chapter 22: Anti-Parkinson's Drugs Market Customer Information

  • Significant Impact of Parkinson's Disease on Quality of Life
  • Knowledge Gaps among Parkinson's Patients and Caregivers
  • Parkinson's Awareness in UK
  • Knowledge on Parkinson's Disease among Patients and General Neurologists
  • Power of Placebo

Chapter 23: Anti-Parkinson's Drugs Market Competitive Landscape

  • Company Profiles

Chapter 24: Key Mergers and Acquisitions in the Anti-Parkinson's Drugs Market

  • Teva Pharmaceutical Acquired Auspex Pharmaceuticals
  • Mitsubishi Tanabe Acquired NeuroDerm
  • Sunovion Pharmaceuticals Acquired Cynapsus Therapeutics
  • Acorda Therapeutics Acquired Civitas Therapeutics
  • Acorda Therapeutics Acquired Biotie Therapies

Appendix

  • Definitions of the Industry
    • Anti-Parkinson's Drugs
    • Research Methodology

About BCC Research

  • About BCC Research
  • BCC Membership
  • BCC Custom Research

List of Tables

  • Summary Table: Global Anti-Parkinson's Drugs Forecast Market, Through 2022 ($ Millions)
    • Table 1: Global Anti-Parkinson's Drugs Historic Market, Through 2017 ($ Millions)
    • Table 2: Global Anti-Parkinson's Drugs Forecast Market, Through 2022 ($ Millions)
    • Table 3: Global Anti-Parkinson's Drugs Market, by Segment, 2017 (%/$ Millions)
    • Table 4: Global Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013- 2022 (%)
    • Table 5: Global Anti-Parkinson's Drugs Market, by Region, 2017 (%/$ Millions)
    • Table 6: Global Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Region, 2013-2022 (%)
    • Table 7: Global Anti-Parkinson's Drugs Market Segmentation, by Region, 2017 ($ Millions/%)
    • Table 8: Global Anti-Parkinson's Drugs Market, by Country, 2017 (%/$ Millions)
    • Table 9: Global Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Country, 2013- 2022 (%)
    • Table 10: Global Anti-Parkinson's Drugs Market Segmentation, by Country, 2017 ($ Millions/%)
    • Table 11: Global Per Capita Average Anti-Parkinson's Drugs Market Expenditure, 2013-2022 ($)
    • Table 12: Per Capita Average Anti-Parkinson's Drugs Market Expenditure, by Country, 2017 ($)
    • Table 13: Asia-Pacific-Anti-Parkinson's Drugs Historic Market, Through 2017 ($ Millions)
    • Table 14: Asia-Pacific Anti-Parkinson's Drugs Forecast Market, Through 2022 ($ Millions)
    • Table 15: Asia-Pacific Anti-Parkinson's Drugs Market, by Segment, 2017 (%/$ Millions)
    • Table 16: Asia-Pacific Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022 (%)
    • Table 17: China Anti-Parkinson's Drugs Historic Market, Through 2017 ($ Millions)
    • Table 18: China Anti-Parkinson's Drugs Forecast Market, Through 2022 ($ Millions)
    • Table 19: China Anti-Parkinson's Drugs Market, by Segment, 2017 (%/$ Millions)
    • Table 20: China Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013- 2022 (%)
    • Table 21: India Anti-Parkinson's Drugs Historic Market, Through 2017 ($ Millions)
    • Table 22: India Anti-Parkinson's Drugs Forecast Market, Through 2022 ($ Millions)
    • Table 23: India Anti-Parkinson's Drugs Market, by Segment, 2017 (%/$ Millions)
    • Table 24: India Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013- 2022 (%)
    • Table 25: Japan Anti-Parkinson's Drugs Historic Market, Through 2017 ($ Millions)
    • Table 26: Japan Anti-Parkinson's Drugs Forecast Market, Through 2022 ($ Millions)
    • Table 27: Japan Anti-Parkinson's Drugs Market, by Segment, 2017 (%/$ Millions)
    • Table 28: Japan Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013- 2022 (%)
    • Table 29: Australia Anti-Parkinson's Drugs Historic Market, Through 2017 ($ Millions)
    • Table 30: Australia Anti-Parkinson's Drugs Forecast Market, Through 2022 ($ Millions)
    • Table 31: Australia Anti-Parkinson's Drugs Market, by Segment, 2017 (%/$ Millions)
    • Table 32: Australia Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022 (%)
    • Table 33: Western Europe Anti-Parkinson's Drugs Historic Market, Through 2017 ($ Millions)
    • Table 34: Western Europe Anti-Parkinson's Drugs Forecast Market, Through 2022 ($ Millions)
    • Table 35: Western Europe Anti-Parkinson's Drugs Market, by Segment, 2017 (%/$ Millions)
    • Table 36: Western Europe Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022 (%)
    • Table 37: UK Anti-Parkinson's Drugs Historic Market, Through 2017 ($ Millions)
    • Table 38: UK Anti-Parkinson's Drugs Forecast Market, Through 2022 ($ Millions)
    • Table 39: UK Anti-Parkinson's Drugs Market, by Segment, 2017 (%/$ Millions)
    • Table 40: UK Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022 (%)
    • Table 41: Germany Anti-Parkinson's Drugs Historic Market, Through 2017 ($ Millions)
    • Table 42: Germany Anti-Parkinson's Drugs Forecast Market, Through 2022, ($ Millions)
    • Table 43: Germany Anti-Parkinson's Drugs Market, by Segment, 2017 (%/$ Millions)
    • Table 44: Germany Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022 (%)
    • Table 45: France Anti-Parkinson's Drugs Historic Market, Through 2017 ($ Millions)
    • Table 46: France Anti-Parkinson's Drugs Forecast Market, Through 2022 ($ Millions)
    • Table 47: France Anti-Parkinson's Drugs Market, by Segment, 2017 (%/$ Millions)
    • Table 48: France Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013- 2022 (%)
    • Table 49: Italy Anti-Parkinson's Drugs Historic Market, Through 2017 ($ Millions)
    • Table 50: Italy Anti-Parkinson's Drugs Forecast Market, Through 2022 ($ Millions)
    • Table 51: Italy Anti-Parkinson's Drugs Market, by Segment, 2017 (%/$ Millions)
    • Table 52: Italy Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013- 2022 (%)
    • Table 53: Spain Anti-Parkinson's Drugs Historic Market, Through 2017 ($ Millions)
    • Table 54: Spain Anti-Parkinson's Drugs Forecast Market, 2017-2022 ($ Millions)
    • Table 55: Spain Anti-Parkinson's Drugs Market, by Segment, 2017 (%/$ Millions)
    • Table 56: Spain Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013- 2022 (%)
    • Table 57: Eastern Europe Anti-Parkinson's Drugs Historic Market, Through 2017 ($ Millions)
    • Table 58: Eastern Europe Anti-Parkinson's Drugs Forecast Market, Through 2022 ($ Millions)
    • Table 59: Eastern Europe Anti-Parkinson's Drugs Market, by Segment, 2017 (%/$ Millions)
    • Table 60: Eastern Europe Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022 (%)
    • Table 61: Russia Anti-Parkinson's Drugs Historic Market, Through 2017 ($ Millions)
    • Table 62: Russia Anti-Parkinson's Drugs Forecast Market, Through 2022 ($ Millions)
    • Table 63: Russia Anti-Parkinson's Drugs Market, by Segment, 2017 (%/$ Millions)
    • Table 64: Russia Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013- 2022 (%)
    • Table 65: North America Anti-Parkinson's Drugs Historic Market, Through 2017 ($ Millions)
    • Table 66: North America Anti-Parkinson's Drugs Forecast Market, Through 2022 ($ Millions)
    • Table 67: North America Anti-Parkinson's Drugs Market, by Segment, 2017 (%/$ Millions)
    • Table 68: North America Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022 (%)
    • Table 69: USA Anti-Parkinson's Drugs Historic Market, Through 2017 ($ Millions)
    • Table 70: USA Anti-Parkinson's Drugs Forecast Market, Through 2022 ($ Millions)
    • Table 71: USA Anti-Parkinson's Drugs Market, by Segment, 2017 ($ Millions)
    • Table 72: USA Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013- 2022 (%)
    • Table 73: South America Anti-Parkinson's Drugs Historic Market, Through 2017 ($ Millions)
    • Table 74: South America Anti-Parkinson's Drugs Forecast Market, Through 2022 ($ Millions)
    • Table 75: South America Anti-Parkinson's Drugs Market, by Segment, 2017 (%/$ Millions)
    • Table 76: South America Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022 (%)
    • Table 77: Brazil Anti-Parkinson's Drugs Historic Market, Through 2017 ($ Millions)
    • Table 78: Brazil Anti-Parkinson's Drugs Forecast Market, Through 2022 ($ Millions)
    • Table 79: Brazil Anti-Parkinson's Drugs Market, by Segment, 2017 (%/$ Millions)
    • Table 80: Brazil Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013- 2022 (%)
    • Table 81: Middle East Anti-Parkinson's Drugs Historic Market, Through 2017 ($ Millions)
    • Table 82: Middle East Anti-Parkinson's Drugs Forecast Market, Through 2022 ($ Millions)
    • Table 83: Middle East Anti-Parkinson's Drugs Market, by Segment, 2017 (%/$ Millions)
    • Table 84: Middle East Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022 (%)
    • Table 85: Africa Anti-Parkinson's Drugs Historic Market, 2013-2017 ($ Millions)
    • Table 86: Africa Anti-Parkinson's Drugs Forecast Market, Through 2022 ($ Millions)
    • Table 87: Africa Anti-Parkinson's Drugs Market, by Segment, 2017 (%/$ Millions)
    • Table 88: Africa Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013- 2022 (%)
    • Table 89: Global Market Share for Key Competitors of Anti-Parkinson's Drugs, 2017 (%/$ Millions)
    • Table 90: AbbVie Inc.: Financial Performance, 2013-2017 ($ Billions)
    • Table 91: Boehringer Ingelheim: Financial Performance, 2013-2016 ($ Billions)
    • Table 92: F. Hoffmann-La Roche: Financial Performance, 2013-2016 ($ Billions)
    • Table 93: Novartis AG: Financial Performance, 2013-2017 ($ Billions)
    • Table 94: UCB SA: Financial Performance, 2013-2017 ($ Billions)
    • Table 95: Market Data Sources

List of Figures

  • Summary Figure: Global Anti-Parkinson's Drugs Forecast Market, 2017-2022 ($ Millions)
    • Figure 1: Global Anti-Parkinson's Drugs Historic Market, 2013-2017 ($ Millions)
    • Figure 2: Global Anti-Parkinson's Drugs Forecast Market, 2017-2022 ($ Millions)
    • Figure 3: PESTLE Analysis: Global Anti-Parkinson's Drugs Market, 2017
    • Figure 4: Global Anti-Parkinson's Drugs Market Share, by Segment, 2017 (%)
    • Figure 5: Global Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013- 2022 (%)
    • Figure 6: Global Anti-Parkinson's Drugs Market Share, by Region, 2017 (%)
    • Figure 7: Global Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Region, 2013- 2022 (%)
    • Figure 8: Global Anti-Parkinson's Drugs Market Segmentation, by Region, 2017, ($ Millions/%)
    • Figure 9: Global Anti-Parkinson's Drugs Market Share, by Country, 2017 (%)
    • Figure 10: Global Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Country, 2013- 2022 (%)
    • Figure 11: Global Anti-Parkinson's Drugs Market Segmentation, by Country, 2017 ($ Millions)
    • Figure 12: Global Per Capita Average Anti-Parkinson's Drugs Market Expenditure, 2013-2022 ($)
    • Figure 13: Asia-Pacific Anti-Parkinson's Drugs Historic Market, 2013-2017 ($ Millions)
    • Figure 14: Asia-Pacific Anti-Parkinson's Drugs Forecast Market, 2017-2022 ($ Millions)
    • Figure 15: Asia-Pacific Anti-Parkinson's Drugs Market, by Segment, 2017 (%)
    • Figure 16: Asia-Pacific Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022 (%)
    • Figure 17: China Anti-Parkinson's Drugs Historic Market, 2013-2017 ($ Millions)
    • Figure 18: China Anti-Parkinson's Drugs Forecast Market, 2017-2022 ($ Millions)
    • Figure 19: China Anti-Parkinson's Drugs Market Share, by Segment, 2017 (%)
    • Figure 20: China Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013- 2022 (%)
    • Figure 21: India Anti-Parkinson's Drugs Historic Market, 2013-2017 ($ Millions)
    • Figure 22: India Anti-Parkinson's Drugs Forecast Market, 2017-2022 ($ Millions)
    • Figure 23: India Anti-Parkinson's Drugs Market, by Segment, 2017 (%)
    • Figure 24: India Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013- 2022 (%)
    • Figure 25: Japan Anti-Parkinson's Drugs Historic Market, 2013-2017 ($ Millions)
    • Figure 26: Japan Anti-Parkinson's Drugs Forecast Market, 2017-2022 ($ Millions)
    • Figure 27: Japan Anti-Parkinson's Drugs Market, by Segment, 2017 ($ Millions)
    • Figure 28: Japan Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013- 2022 (%)
    • Figure 29: Australia Anti-Parkinson's Drugs Historic Market, 2013-2017 ($ Millions)
    • Figure 30: Australia Anti-Parkinson's Drugs Forecast Market, 2017-2022 ($ Millions)
    • Figure 31: Australia Anti-Parkinson's Drugs Market Share, by Segment, 2017 (%)
    • Figure 32: Australia Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022 (%)
    • Figure 33: Western Europe Anti-Parkinson's Drugs Historic Market, 2013-2017 ($ Millions)
    • Figure 34: Western Europe Anti-Parkinson's Drugs Forecast Market, 2017-2022 ($ Millions)
    • Figure 35: Western Europe Anti-Parkinson's Drugs Market, by Segment, 2017 ($ Millions)
    • Figure 36: Western Europe Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022 (%)
    • Figure 37: UK Anti-Parkinson's Drugs Historic Market, 2013-2017 ($ Millions)
    • Figure 38: UK Anti-Parkinson's Drugs Forecast Market, 2017-2022 ($ Millions)
    • Figure 39: UK Anti-Parkinson's Drugs Market, by Segment, 2017 (%)
    • Figure 40: UK Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013- 2022 (%)
    • Figure 41: Germany Anti-Parkinson's Drugs Historic Market, 2013-2017 ($ Millions)
    • Figure 42: Germany Anti-Parkinson's Drugs Forecast Market, 2017-2022 ($ Millions)
    • Figure 43: Germany Anti-Parkinson's Drugs Market, by Segment, 2017 (%)
    • Figure 44: Germany Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022 (%)
    • Figure 45: France Anti-Parkinson's Drugs Historic Market, 2013-2017 ($ Millions)
    • Figure 46: France Anti-Parkinson's Drugs Forecast Market, 2017-2022 ($ Millions)
    • Figure 47: France Anti-Parkinson's Drugs Market, by Segment, 2017 ($ Millions)
    • Figure 48: France Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013- 2022 (%)
    • Figure 49: Italy Anti-Parkinson's Drugs Historic Market, 2013-2017 ($ Millions)
    • Figure 50: Italy Anti-Parkinson's Drugs Forecast Market, 2017-2022 ($ Millions)
    • Figure 51: Italy Anti-Parkinson's Drugs Market, by Segment, 2017 (%)
    • Figure 52: Italy Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013- 2022 (%)
    • Figure 53: Spain Anti-Parkinson's Drugs Historic Market, 2013-2017 ($ Millions)
    • Figure 54: Spain Anti-Parkinson's Drugs Forecast Market, 2017-2022 ($ Millions)
    • Figure 55: Spain Anti-Parkinson's Drugs Market, by Segment, 2017 (%)
    • Figure 56: Spain Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013- 2022 (%)
    • Figure 57: Eastern Europe Anti-Parkinson's Drugs Historic Market, 2013-2017 ($ Millions)
    • Figure 58: Eastern Europe Anti-Parkinson's Drugs Forecast Market, 2017-2022 ($ Millions)
    • Figure 59: Eastern Europe Anti-Parkinson's Drugs Market, by Segment, 2017 (%)
    • Figure 60: Eastern Europe Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022 (%)
    • Figure 61: Russia Anti-Parkinson's Drugs Historic Market, 2013-2017 ($ Millions)
    • Figure 62: Russia Anti-Parkinson's Drugs Forecast Market, 2017-2022 ($ Millions)
    • Figure 63: Russia Anti-Parkinson's Drugs Market, by Segment, 2017 (%)
    • Figure 64: Russia Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013- 2022 (%)
    • Figure 65: North America Anti-Parkinson's Drugs Historic Market, 2013-2017 ($ Millions)
    • Figure 66: North America Anti-Parkinson's Drugs Forecast Market, 2017-2022 ($ Millions)
    • Figure 67: North America Anti-Parkinson's Drugs Market, by Segment, 2017 (%)
    • Figure 68: North America Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022 (%)
    • Figure 69: USA Anti-Parkinson's Drugs Historic Market, 2013-2017 ($ Millions)
    • Figure 70: USA Anti-Parkinson's Drugs Forecast Market, 2017-2022 ($ Millions)
    • Figure 71: USA Anti-Parkinson's Drugs Market, by Segment, 2017 (%)
    • Figure 72: USA Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013- 2022 (%)
    • Figure 73: South America Anti-Parkinson's Drugs Historic Market, 2013-2017 ($ Millions)
    • Figure 74: South America Anti-Parkinson's Drugs Forecast Market, 2017-2022 ($ Millions)
    • Figure 75: South America Anti-Parkinson's Drugs Market, by Segment, 2017 ($ Millions)
    • Figure 76: South America Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022 (%)
    • Figure 77: Brazil Anti-Parkinson's Drugs Historic Market, 2013-2017 ($ Millions)
    • Figure 78: Brazil Anti-Parkinson's Drugs Forecast Market, 2017-2022 ($ Millions)
    • Figure 79: Brazil Anti-Parkinson's Drugs Market, by Segment, 2017 (%)
    • Figure 80: Brazil Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013- 2022 (%)
    • Figure 81: Middle East Anti-Parkinson's Drugs Historic Market, 2013-2017 ($ Millions)
    • Figure 82: Middle East Anti-Parkinson's Drugs Forecast Market, 2017-2022 ($ Millions)
    • Figure 83: Middle East Anti-Parkinson's Drugs Market, by Segment, 2017 (%)
    • Figure 84: Middle East Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013-2022 (%)
    • Figure 85: Africa Anti-Parkinson's Drugs Historic Market, 2013-2017 ($ Millions)
    • Figure 86: Africa Anti-Parkinson's Drugs Forecast Market, 2017-2022 ($ Millions)
    • Figure 87: Africa Anti-Parkinson's Drugs Market, by Segment, 2017 (%)
    • Figure 88: Africa Anti-Parkinson's Drugs Market, Historic and Forecast Growth Rate, by Segment, 2013- 2022 (%)
    • Figure 89: Global Market Share for Key Competitors of Anti-Parkinson's Drugs, 2017, (%)
    • Figure 90: AbbVie Inc.: Financial Performance, 2013-2017 ($ Billions)
    • Figure 91: Boehringer Ingelheim: Financial Performance, 2013-2016 ($ Billions)
    • Figure 92: F. Hoffmann-La Roche: Financial Performance, 2013-2017 ($ Billions)
    • Figure 93: Novartis AG: Financial Performance, 2013-2017 ($ Billions)
    • Figure 94: UCB SA: Financial Performance, 2013-2017 ($ Billions)
Back to Top